Azacitidine injection 150mg “Ohhara”, manufactured by Ohara Pharmaceutical, contains Azacitidine. With YJ code 4291419D2030 and standard 150mg 1 bottle, it is used for the treatment of myelodysplastic syndrome and acute myeloid leukemia.
Azacitidine injection 150mg “Ohhara”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →